Bisphosphonates are effective in reducing hip and osteoporotic fractures. However, concerns about atypical femur fractures have contributed to substantially decreased bisphosphonate use, and the ...
Osteoporosis, a disease characterized by reduced bone mass and increased skeletal fragility, affects 10 million Americans; another 34 million are at risk for it. Bisphosphonates are widely prescribed ...
A 66-year-old woman who began treatment with alendronate 6 months ago for osteoporosis presents to your office for medical clearance prior to dental work.
Medication-related osteonecrosis of the jaw (MRONJ), a condition in which there is persistent necrotic bone on the mandible and maxilla, can be a side effect of using bisphosphonates. Root canal ...
Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study ...
Professor of Medicine; Rathmann Family Foundation Endowed Chair for Patient-Centered Clinical Education, University of Washington School of Medicine, Seattle, Washington Disclosure: Douglas S. Paauw, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results